LENSAR (NASDAQ:LNSR) Stock Price Up 0.1% - Still a Buy?

Shares of LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) traded up 0.1% on Wednesday . The stock traded as high as $13.95 and last traded at $13.84. 128,828 shares changed hands during mid-day trading, an increase of 83% from the average session volume of 70,280 shares. The stock had previously closed at $13.82.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. BTIG Research downgraded LENSAR from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 24th. Lake Street Capital restated a "hold" rating and issued a $15.00 price target (down from $16.00) on shares of LENSAR in a research note on Monday, March 24th.

LENSAR Stock Up 0.1 %

The stock's 50 day moving average is $13.70 and its 200-day moving average is $10.01. The company has a market cap of $165.64 million, a PE ratio of -9.62 and a beta of 0.56.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported ($1.61) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($1.40). LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The business had revenue of $16.73 million during the quarter, compared to the consensus estimate of $14.95 million.

Institutional Trading of LENSAR

A number of large investors have recently made changes to their positions in LNSR. Evernest Financial Advisors LLC bought a new stake in shares of LENSAR in the 4th quarter worth about $174,000. Bailard Inc. bought a new stake in shares of LENSAR in the 4th quarter worth about $181,000. Atria Investments Inc increased its holdings in shares of LENSAR by 28.2% in the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after buying an additional 5,729 shares during the last quarter. Essex Investment Management Co. LLC grew its holdings in LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after purchasing an additional 6,184 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock valued at $460,000 after purchasing an additional 3,423 shares during the last quarter. 40.15% of the stock is currently owned by institutional investors.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.